Quantcast
Last updated on April 20, 2014 at 1:20 EDT

Latest Guangxi Wuzhou Zhongheng Group Co. Ltd Stories

2012-10-29 07:25:57

VANCOUVER, Oct. 29, 2012 /PRNewswire/ -- Del Mar Pharmaceuticals (BC) Ltd. ("DelMar") today announced a strategic collaboration with Guangxi Wuzhou Pharmaceutical Company, a subsidiary of publicly traded Guangxi Wuzhou Zhongheng Group Co., Ltd (SHG 600252) for the development of VAL-083, known as "DAG for Injection" in China. DAG for Injection in China, is approved by the Chinese State Food and Drug Administration (SFDA) as a cancer chemotherapy for the treatment of Chronic Myelogenous...